Bortezomib vs no bortezomib
Overall Survival ‐ Bortezomib versus no bortezomib (different background therapy or other agents) · All patients with a diagnosis of multiple myeloma
Bortezomib leads to lower overall Survival ‐ Bortezomib versus no bortezomib (different… compared with no bortezomib (high certainty).
1 finding from 1 review
- Odds Ratio 0.76 [0.67, 0.88]5 studies · 2532 participantsHigh